EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for ARVN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 -3.256
December 31, 2025 -1.216
September 30, 2025 -0.8031
June 30, 2025 -1.006
March 31, 2025 -0.6572
December 31, 2024 -2.765
September 30, 2024 -4.674
June 30, 2024 -5.174
March 31, 2024 -5.932
December 31, 2023 -6.500
September 30, 2023 -5.525
June 30, 2023 -5.586
March 31, 2023 -5.655
December 31, 2022 -5.315
September 30, 2022 -4.760
June 30, 2022 -4.454
March 31, 2022 -4.168
December 31, 2021 -3.814
September 30, 2021 -3.805
Date Value
June 30, 2021 -3.656
March 31, 2021 -3.278
December 31, 2020 -2.999
September 30, 2020 -2.568
June 30, 2020 -2.319
March 31, 2020 -2.214
December 31, 2019 -2.109
September 30, 2019 -3.227
June 30, 2019 -6.564
March 31, 2019 -6.724
December 31, 2018 -8.616
September 30, 2018 -7.224
June 30, 2018 -3.545
March 31, 2018 -3.048
December 31, 2017 -0.8899
September 30, 2017 -0.6008
June 30, 2017 -0.4019
March 31, 2017 -0.1942

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Septerna, Inc. -0.8171
Pfizer Inc. 1.304
Cocrystal Pharma, Inc. -0.7312
CNBX Pharmaceuticals, Inc. -0.0019
GB Sciences, Inc. --